Combination of a calcium channel blocker and thromboxane A2 receptor antagonist or synthetase inhibitor and method for treating ischemia employing such combination.

摘要

A method is provided for treating ischemia in a mammalian species by administering a combination of a calcium channel blocker such as diltiazem, SQ 31,765 or SQ 32,324 and a thromboxane A2 receptor antagonist such as SQ 30,741 or a thromboxane synthetase inhibitor such as dazoxiben.